<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03865966</url>
  </required_header>
  <id_info>
    <org_study_id>2019-24</org_study_id>
    <nct_id>NCT03865966</nct_id>
  </id_info>
  <brief_title>Hepatitis B Virus Infection After Liver Transplantation in Children</brief_title>
  <official_title>Clinical Follow-up Study on Hepatitis B Virus Infection After Liver Transplantation in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Qiu Li</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Hospital of Chongqing Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      China is a highly prevalent area of hepatitis B virus（HBV） infection, with at least 75
      million hepatitis B virus carriers, and 80% of primary hepatocellular carcinoma (HCC) is
      associated with chronic hepatitis B virus infection. Liver transplantation is currently the
      preferred method for end-stage liver disease such as biliary atresia and cirrhosis in
      children. In recent years, children's liver transplantation has developed rapidly and the
      number of developments has increased significantly. If there is chronic hepatitis B virus
      infection in the donor liver, it may cause HBV transmission, or the patient may have a
      low-load occult hepatitis B virus infection, and after immunosuppressive treatment, it may
      lead to hepatitis B virus infection after surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">July 5, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The rate of occult hepatitis b virus infection</measure>
    <time_frame>3-5 years</time_frame>
    <description>Clinical follow-up testing for occult HBV infection after liver transplantation in children</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The rate of overt hepatitis b virus infection</measure>
    <time_frame>3-5 years</time_frame>
    <description>Clinical follow-up testing for overt HBV infection after liver transplantation in children</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The levels and changes of anti-HBs after liver transplantation</measure>
    <time_frame>3-5 years</time_frame>
    <description>Clinical follow-up testing for HBV seromarkers after liver transplantation in children</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Hepatitis B Infection</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Peripheral blood and liver tissue specimens。
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        End-stage liver disease requires liver transplantation.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with end-stage liver disease who require liver transplantation

        Exclusion Criteria:

          -  Children without liver transplantation refer to children;

          -  Children who are unwilling to participate;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yao Zhao</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chongqing Children's Hospital of Chongqing Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yao Zhao</last_name>
    <phone>+862363603083</phone>
    <email>Zhaoy@cqmu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chongqing Children's Hospital of Chongqing Medical University</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400014</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yao Zhao</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>March 4, 2019</study_first_submitted>
  <study_first_submitted_qc>March 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 7, 2019</study_first_posted>
  <last_update_submitted>July 4, 2019</last_update_submitted>
  <last_update_submitted_qc>July 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Children's Hospital of Chongqing Medical University</investigator_affiliation>
    <investigator_full_name>Qiu Li</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Hepatitis B</mesh_term>
    <mesh_term>Herpesviridae Infections</mesh_term>
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Virus Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>3-5 years</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

